Franklin C Harwood

Author PubWeight™ 9.86^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1).	Mol Cell	2003	1.84
2	Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro.	Cancer Res	2004	1.47
3	Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice.	Cancer Res	2004	1.41
4	4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.	J Biol Chem	2002	1.37
5	Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.	J Biol Chem	2004	1.37
6	Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors.	Mol Cancer Ther	2007	1.28
7	Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.	Cancer Res	2003	1.26